Get a rundown of the FDA's 20 novel drug approvals from the first half of 2024 in the first edition of the Provider's Digest, a monthly LinkedIn newsletter spotlighting regulatory decisions and approvals from the US Food and Drug Administration. Subscribe to get a monthly recap of FDA news from the prior month every first Saturday of each month! #FDANews #Healthcare #Medicine
HCPLive
Media Production
Cranbury, NJ 2,988 followers
Comprehensive clinical news that provide clinicians with up-to-date specialty and disease-specific information.
About us
HCPLive provides health care professionals with up-to-date specialty and disease-specific news, clinical information, and other resources to help provide better care to patients. On HCPLive.com, you will find in-depth conference coverage and information about upcoming meetings, perspective on regulatory news, and multimedia content featuring key opinion leaders. Get all the latest news on individual medical conditions in our "condition centers": • Cardiology • Endocrinology • Gastroenterology • Ophthalmology • Neurology • Pain Management • Pediatrics • Primary Care • Psychiatry • Rheumatology • Urology
- Website
-
http://www.HCPLive.com
External link for HCPLive
- Industry
- Media Production
- Company size
- 2-10 employees
- Headquarters
- Cranbury, NJ
- Type
- Privately Held
- Founded
- 1957
- Specialties
- Managed Care, primary care, family medicine, Healthcare news, Internal Medicine, Medicine, Medical News, FDA News, and Cardiology
Locations
-
Primary
2 Clarke Drive
Suite 100
Cranbury, NJ 08512, US
Employees at HCPLive
Updates
-
Dr. Emile Bacha, Director of Congenital Pediatric Cardiac Surgery at NewYork Presbyterian Morgan Stanley Children's Hospital, collaborated with a multidisciplinary team of specialists to repair a young boy's heart. Learn more about the complex case. Watch the video: bit.ly/3VDuLww
-
-
BREAKING: Roflumilast cream 0.15% (ZVORYVE; Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)) has received FDA approval for treatment of mild to moderate atopic dermatitis in adult and pediatric patients 6 years of age and older. Learn more about the once-daily cream and supporting data from the INTEGUMENT program: https://lnkd.in/evvxtJ5Q #AtopicDermatits Lawrence Eichenfield #Dermatology
-
-
This morning, Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) offered the #dermatology community an update on their sNDA for roflumilast cream 0.15% in the management of atopic dermatitis. According to the company, the FDA indicated they are working to finalize the action letter and have not indicated they would extend the Prescription Drug User Fee Act goal date of July 7, 2024. https://lnkd.in/exH236YR #AtopicDermatitis
-
-
Check out the latest episode of #NewInsight with Dr. Veeral Sheth and learn more about gildeuretinol!
I'm thrilled to share the latest episode of the HCPLive New Insight podcast with you all! In this episode, we dive into the groundbreaking work of Alkeus Pharmaceuticals, Inc. and their lead candidate for the treatment of Stargardt Disease and Geographic Atrophy. I had the privilege of speaking with Seemi Khan, MD, MPH, MBA, the Chief Medical Officer at Alkeus Pharmaceuticals. Dr. Khan's extensive background in rare diseases brings a wealth of knowledge and passion to the conversation. We discuss her journey, the challenges and triumphs in the field of rare diseases, and some of the promising early results of their innovative medication. Whether you're in the pharmaceutical industry, a healthcare professional, or simply interested in cutting-edge medical advancements, this episode is a must-listen! Tune in now and join us as we explore the future of treatment for Stargardt Disease.
New Insight: A Look at Gildeuretinol (ALK-001) for Stargardt Disease w/ Seemi Khan, MD
hcplive.com
-
What novel treatments for central sleep apnea came out in the past 10 years? Check out this interview with Saf Badr, MD, MBA, Wayne State University: https://lnkd.in/eqe_9gTm #SleepApnea #SleepHealth
-
-
A new analysis of real-world data from Truveta led by Tricia Rodriguez, PhD, MPH, Ty J. Gluckman, FACC, FAHA, and Nick Stucky, MD, PhD, suggests tirzepatide provides greater body weight reductions than semaglutide. Learn more: https://lnkd.in/etvQ3ncy #Obesity #WeightLoss #Healthcare
-
-
Exclusive coverage 🔒: Our rundown of 7 highly anticipated #FDA decisions for the rest of 2024. Here's a spoiler from the first decision: vonoprazan for non-erosive #GERD. Sign up to read / listen about the other 6: https://lnkd.in/eW3aD-jx
-
-
Sunday Spotlight: In a recent interview, Diana Girnita MD, PhD, founder and CEO of Rheumatologist OnCall, discusses the role of patient education and the importance of reliable, accessible information. Hear from Girnita as she explains how she tailors her communication to ensure complex medical information is accessible to patients in the evolving landscape of digital platforms. https://lnkd.in/eb7hTiit #Rheumatology #Healthcare
-
Learn more about the benefits of new AID systems and other diabetes technology in our ADA 2024 diabetes technology recap episode of #DiabetesDialogue with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES. https://lnkd.in/eEmPHr_6 #Diabetes #DiabetesTechnology